Equillium (EQ) Narx-foyda koeffitsiyenti
Autoimmun patologiyalar uchun davolash vositalarini ishlab chiqish kapitalga boy biotexnologik gigantlar tomonidan kuchli bosimga duch kelmoqda. GURU.Markets dagi tarixiy narxlar dinamikasi joriy P/E koeffitsiyenti -4.90 ekanligini ko'rsatmoqda. Equillium, Inc. (EQ) immunologiya sohasidagi nufuziga va itolizumab muvaffaqiyatiga tayanadi. Noyob antitelalar uchun patent himoyasi va Osiyo hamkorlaridan keladigan muntazam litsenziya to'lovlari barqarorlikni ta'minlaydi.
Equillium Inc (EQ) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- bozor qiymati va tahlilchilarning maqsadli prognozi:
- bozor kapitallashuvi tafsilotlari:
- balans bo'yicha xususiy kapital ma'lumotlari:
- kompaniyaning majburiyatlari va likvidligi ma'lumotlari:
Qarzning xususiy kapitalga nisbati Equillium, Inc.|EQ - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli majburiyatlarning kapitalga nisbati Equillium Bio|EQ - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Equillium, Inc.|EQ - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli qarzdorlik Equillium|Tezkor likvidlik koeffitsiyenti equilliumbio.com
- kompaniyaning daromadliligi va baholash multiplikatorlari ko'rsatkichlari:
EQ - Sof foyda|Kompaniya foydasi prognozi Equillium, Inc.|EQ - Narxning foydaga nisbati|Kelajakdagi narxning foydaga nisbati Equillium Bio|EQ - Narxning foydaga va o‘sish sur’atiga nisbati|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Equillium, Inc.|EQ - EBITDA operatsion foydasi|So'nggi to'rtta chorak uchun bir aksiya uchun sof foyda Equillium|EQ - So'nggi 12 oy davomida bir aksiya uchun sof foyda|Choraklik EPS foyda o'sishi equilliumbio.com|EQ - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yil uchun bir aksiya uchun kutilayotgan foyda o'sishi Equillium, Inc.
Kompaniyaning jamlanma tahlili:EQ (equilliumbio.com)
Uzoq muddatli investor uchun Equillium, Inc. (EQ) ishonchliligi uning tor doiradagi immunoterapiya ishlab chiqish profili va Hindistonning sog'liqni saqlash giganti bilan strategik sherikligi o'rtasidagi muvozanat bilan belgilanadi. P/E koeffitsiyenti dinamikasini tahlil qilishda, ushbu koeffitsiyent biznesning bozor qiymatini uning sof foydasiga bog'lashini tushunish muhimdir, bu esa foyda birligi uchun xarajatlarni baholash imkonini beradi va haqiqiy moliyaviy natijalarga nisbatan aktivlarning haddan tashqari qimmat baholanganlik darajasini aniqlaydi.
Raqobatdosh kompaniyalar tahlili
argenx.com (ARGX) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati BioNTech (BNTX)|Narx-foyda koeffitsiyenti ABIVAX ABVX|Narxning foydaga nisbati ADMA Bio ADMA|PTGX - Narx-foyda koeffitsiyenti|IMVT: Narx-foyda koeffitsiyenti|KNSA - P/E multiplikatori|Grifols (GRFS) - Narxning foydaga nisbati|Narx-foyda multiplikatori ADPT|CLDX (Celldex) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Aurinia Corp AUPH|P/E multiplikatori BCRX|VERA - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati Dianthus Therapeutics, Inc. DNTH|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti Pharvaris NV|ABCL: Narx-foyda koeffitsiyenti|TRML - P/E multiplikatori|PGEN: P/E multiplikatori|PHAR - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Nektar Therapeutics Inc.|Narxning foydaga nisbati UPB|Narxning foydaga nisbati Zenas Biopharma, Inc. (ZBIO)|Narxning foydaga nisbati IMNM (Immunome Bio)|P/E multiplikatori GOSS (Gossamer Bio, Inc.)|Biznesning o‘zini qoplash muddati kalvista.com (KALV)|SEPN: Narx-foyda koeffitsiyenti|PVLA - P/E multiplikatori|Savara Corp (SVRA) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Rigel Corp|Narx-foyda koeffitsiyenti ANAB|ATXS: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ENGN|Biznesning o‘zini qoplash muddati RAPT Therapeutics Inc.|Narxning foydaga nisbati Aerovate Therapeutics JBIO|ACRS: Narx-foyda multiplikatori|Kyverna Therapeutics - P/E multiplikatori|tizianalifesciences.com (TLSA) - Narx-foyda koeffitsiyenti|CABA (Cabaletta Bio) - Narx-foyda koeffitsiyenti|VTYX - Biznesning o‘zini qoplash muddati|THTX (Theratechnologies Inc) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Avalo Therapeutics Inc AVTX|Narxning foydaga nisbati Eledon Pharmaceuticals (ELDN)|agenusbio.com (AGEN) - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|Narxning foydaga nisbati Climb Bio CLYM|ZURA (Zura Bio Ltd) - Kapitalizatsiyaning sof foydaga nisbati|aTyr - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati ADAG (Adagene)|IMA: P/E multiplikatori|Shattuck Labs (STTK) - P/E multiplikatori|Narxning foydaga nisbati Connect Biopharma Holdings|IMUX: Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Atara Biotherapeutics (ATRA)|Narx-foyda koeffitsiyenti inflarx.de IFRX|P/E multiplikatori XFOR (X4 Pharmaceuticals)|P/E multiplikatori Adicet Bio Inc. ACET|CELU: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati INMB (INmune Bio Inc)|BRNS: P/E multiplikatori|KZR - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati SAB Biotherapeutics|Narx-foyda koeffitsiyenti akaritx.com (AKTX)|Narxning foydaga nisbati Enlivex Therapeutics (ENLV)|Narx-foyda koeffitsiyenti q32bio.com QTTB|GeoVax Labs Inc - Narx-foyda koeffitsiyenti|P/E multiplikatori Edesa Biotech Corp EDSA|IBIO - Narxning foydaga nisbati|CARM (Carisma Therapeutics) - Narx-foyda multiplikatori|XTLB: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Bolt Biotherapeutics, Inc. (BOLT)|HCWB (HCW Biologics, Inc.) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Aptevo APVO|Narxning foydaga nisbati AIM ImmunoTech Inc. (AIM)|aditxt.com (ADTX) - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|GRI Bio - Narx-foyda koeffitsiyenti|P/E multiplikatori XORTX Therapeutics Inc XRTX|ReShape Lifesciences - P/E multiplikatori|Biznesning o‘zini qoplash muddati Revelation Biosciences Corp REVB|Indaptus Therapeutics (INDP) - Narxning foydaga nisbati|SCNI (scinai.com) - Narxning foydaga nisbati|Narxning foydaga nisbati CalciMedica Inc|Narxning foydaga nisbati AFMD|P/E multiplikatori ALLK|Biznesning o‘zini qoplash muddati hookipapharma.com|IGM Biosciences - Narx-foyda koeffitsiyenti|P/E multiplikatori iteostherapeutics.com ITOS|OCEA - Narxning foydaga nisbati|TC BioPharm (Holdings) Plc (TCBP) - Narx-foyda koeffitsiyenti|THRD (Third Harmonic Bio, Inc) - Narx-foyda koeffitsiyenti
